DrugPatentWatch Database Preview
Drugs in Development Information for Toluene
» See Plans and Pricing
What is the development status for investigational drug Toluene?
Toluene is an investigational drug.
There have been 9 clinical trials for Toluene.
The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2009.
The most common disease conditions in clinical trials are Leukemia, Carcinoma, Hepatocellular, and Melanoma. The leading clinical trial sponsors are National Cancer Institute (NCI), PTS International Inc., and First Affiliated Hospital of Zhejiang University.
Summary for Toluene
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,797 |
| WIPO Patent Applications | 1,710 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2009-08-01) |
| Vendors | 48 |
Recent Clinical Trials for Toluene
| Title | Sponsor | Phase |
|---|---|---|
| Treatment of Non-small Cell Lung Cancer With PD-1 Monoclonal Antibody Combined With Donafenib Toluene Sulfonate | First Affiliated Hospital of Zhejiang University | Phase 1 |
| A Phase II Study of PTS100 in Primary HCC Patients | Gongwin Biopharm Co., Ltd. | Phase 2 |
| A Study of PTS for Patients With Solid Tumors | PTS International Inc. | Phase 1 |
Clinical Trial Summary for Toluene
Top disease conditions for Toluene
Top clinical trial sponsors for Toluene
US Patents for Toluene
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
